Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Coca-Cola Consolidated Inc is a beverages-non-alcoholic business based in the US. Coca-Cola Consolidated shares (COKE) are listed on the NASDAQ and all prices are listed in US Dollars. Coca-Cola Consolidated employs 14,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$396.24|
|52-week range||$222.97 - $459.72|
|50-day moving average||$394.98|
|200-day moving average||$373.50|
|Wall St. target price||$144.00|
|Dividend yield||$1 (0.25%)|
|Earnings per share (TTM)||$23.36|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-2.16%|
|1 month (2021-09-16)||3.39%|
|3 months (2021-07-16)||-4.44%|
|6 months (2021-04-16)||29.15%|
|1 year (2020-10-16)||55.96%|
|2 years (2019-10-16)||36.08%|
|3 years (2018-10-16)||140.16%|
|5 years (2016-10-14)||182.32%|
Valuing Coca-Cola Consolidated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Coca-Cola Consolidated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Coca-Cola Consolidated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Coca-Cola Consolidated shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Coca-Cola Consolidated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $589.9 million.
The EBITDA is a measure of a Coca-Cola Consolidated's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$5.3 billion|
|Operating margin TTM||7.84%|
|Gross profit TTM||$1.8 billion|
|Return on assets TTM||8.04%|
|Return on equity TTM||40.32%|
|Market capitalisation||$3.8 billion|
TTM: trailing 12 months
There are currently 179,205 Coca-Cola Consolidated shares held short by investors – that's known as Coca-Cola Consolidated's "short interest". This figure is 0.3% down from 179,681 last month.
There are a few different ways that this level of interest in shorting Coca-Cola Consolidated shares can be evaluated.
Coca-Cola Consolidated's "short interest ratio" (SIR) is the quantity of Coca-Cola Consolidated shares currently shorted divided by the average quantity of Coca-Cola Consolidated shares traded daily (recently around 16101.078167116). Coca-Cola Consolidated's SIR currently stands at 11.13. In other words for every 100,000 Coca-Cola Consolidated shares traded daily on the market, roughly 11130 shares are currently held short.
However Coca-Cola Consolidated's short interest can also be evaluated against the total number of Coca-Cola Consolidated shares, or, against the total number of tradable Coca-Cola Consolidated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Coca-Cola Consolidated's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Coca-Cola Consolidated shares in existence, roughly 20 shares are currently held short) or 0.0385% of the tradable shares (for every 100,000 tradable Coca-Cola Consolidated shares, roughly 39 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Coca-Cola Consolidated.
Find out more about how you can short Coca-Cola Consolidated stock.
Dividend payout ratio: 3.49% of net profits
Recently Coca-Cola Consolidated has paid out, on average, around 3.49% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.25% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Coca-Cola Consolidated shareholders could enjoy a 0.25% return on their shares, in the form of dividend payments. In Coca-Cola Consolidated's case, that would currently equate to about $1 per share.
While Coca-Cola Consolidated's payout ratio might seem low, this can signify that Coca-Cola Consolidated is investing more in its future growth.
Coca-Cola Consolidated's most recent dividend payout was on 5 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 21 July 2021 (the "ex-dividend date").
Coca-Cola Consolidated's shares were split on a 2:1 basis on 20 March 1984. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Coca-Cola Consolidated shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Coca-Cola Consolidated shares which in turn could have impacted Coca-Cola Consolidated's share price.
Over the last 12 months, Coca-Cola Consolidated's shares have ranged in value from as little as $222.9672 up to $459.7191. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Coca-Cola Consolidated's is 1.0979. This would suggest that Coca-Cola Consolidated's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Coca-Cola Consolidated, Inc. , together with its subsidiaries, produces, markets, and distributes nonalcoholic beverages primarily products of The Coca-Cola Company in the United States. The company offers sparkling beverages, such as carbonated beverages; and still beverages, including energy products, as well as noncarbonated beverages comprising bottled water, tea, ready to drink coffee, enhanced water, juices, and sports drinks. It also sells its products to other Coca-Cola bottlers; and post-mix products that are dispensed through equipment, which mixes the fountain syrup with carbonated or still water enabling fountain retailers to sell finished products to consumers in cups or glasses. In addition, the company distributes products for various other beverage brands that include Dr Pepper and Monster Energy. It sells and distributes its products directly to retail stores and other outlets, which comprise food markets, institutional accounts, and vending machine outlets. The company was formerly known as Coca-Cola Bottling Co.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.